Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EMA Chief: ‘Safety Is Our Priority’ In Review Of COVID-19 Vaccine

Data To Be Made Available Quickly After Approval

Executive Summary

The EMA says its experts are working “around the clock” on a recommendation for conditional marketing authorization of a COVID-19 vaccine, but that it will only OK a vaccine if it is satisfied that the evidence convincingly shows the benefits are greater than the risks.

You may also be interested in...

EU ‘Ready To Approve’ COVID-19 Vaccine On 23 December

European parliamentarians have defended the formal marketing authorization approach being taken by the EU, saying “safety is of the utmost importance” if there is to be trust in coronavirus vaccines.

EMA COVID-19 Vaccine Data Hack: UK Cybersecurity Body Probes Impact

The cyberattack on coronavirus vaccine data held by the European Medicines Agency is the latest in a string of hacks that are also targeting organizations involved with the cold chain distribution of vaccines.

Pfizer Allergy Warning Is First Test Of UK Vaccine Roll-Out

Individuals with history of significant allergic reactions are now being told not to have the vaccine after warnings were not included in healthcare professional information.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts